Stephen Gould
Net worth: 581 $ as of 29/04/2024
Profile
Stephen Gould worked as an Executive Director of Translational Oncology at Genentech, Inc. and as a Senior Director at Curis, Inc. He also served as the Chief Scientific Officer at Atreca, Inc. for a year.
Gould holds a doctorate degree from the University of Connecticut Health Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ATRECA, INC. CLASS A
0.02% | 10/04/2024 | 6,757 ( 0.02% ) | 581 $ | 29/04/2024 |
Former positions of Stephen Gould
| Companies | Position | End |
|---|---|---|
| ATRECA, INC. | Chief Tech/Sci/R&D Officer | 30/12/2023 |
| CURIS, INC. | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Stephen Gould
| University of Connecticut Health Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ATRECA, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen Gould
